Short Interest in Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Rises By 333.0%

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the recipient of a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 12,119 shares, a growth of 333.0% from the May 31st total of 2,799 shares. Currently, 3.7% of the shares of the company are sold short. Based on an average daily trading volume, of 34,902 shares, the days-to-cover ratio is currently 0.3 days.

Defiance Daily Target 2X Long LMND ETF Stock Performance

Shares of NASDAQ LMNX opened at $13.49 on Monday. Defiance Daily Target 2X Long LMND ETF has a 12 month low of $10.17 and a 12 month high of $55.00. The company has a market cap of $4.45 million, a P/E ratio of 26.45 and a beta of 8.07. The business’s 50 day moving average is $14.17 and its two-hundred day moving average is $22.67. The company has a quick ratio of 6.08, a current ratio of 8.37 and a debt-to-equity ratio of 0.52.

About Defiance Daily Target 2X Long LMND ETF

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.